Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101…
Latest Business Update
-
-
The Shiba Inu burn rate witnessed a robust 6200% uptick on Monday, sparking investor optimism globally. As the meme token deals with…
-
Poland Presidential Candidate Slawomir Mentzen has recently pitched for a strategic Bitcoin Reserve as part of his election pitch. Drawing a leaf…
-
Crypto prices today hold steady following last week’s gains. Bitcoin (BTC) remains at $90K. Ethereum (ETH), Solana (SOL), and XRP rise 1-10%.…
-
Cardano has been at the focal center of recent crypto discussions, mainly due to ADA price insane rally of 75% this week.…
-
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates…
-
Investing
68Ga-RAD 301 (68Ga-Trivehexin) Demonstrates Strong Potential for Imaging of αvβ6-Integrin Expression in Pancreatic Cancer Patients
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet…
-
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the development of…
